The global pen needles market size is calculated at USD 4.41 billion in 2025 and is forecasted to reach around USD 11.92 billion by 2034, accelerating at a CAGR of 11.71% from 2025 to 2034. The Europe market size surpassed USD 1.54 billion in 2024 and is expanding at a CAGR of 11.83% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pen Needles Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pen Needles Market Revenue and Volume, by Product
8.1.1 Standard Pen Needles
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Safety Pen Needles
8.1.2.1. Market Revenue and Volume Forecast
9.1. Pen Needles Market Revenue and Volume, by Needle Length
9.1.1. 4 mm
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. 5 mm
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. 6 mm
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. 8 mm
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. 10 mm
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. 12 mm
9.1.6.1. Market Revenue and Volume Forecast
10.1. Pen Needles Market Revenue and Volume, by Therapy
10.1.1. Insulin
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Glucagon-like-Peptide-1 (GLP-1)
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Growth Hormone
10.1.3.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product
11.1.2. Market Revenue and Volume Forecast, by Needle Length
11.1.3. Market Revenue and Volume Forecast, by Therapy
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product
11.1.4.2. Market Revenue and Volume Forecast, by Needle Length
11.1.4.3. Market Revenue and Volume Forecast, by Therapy
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product
11.1.5.2. Market Revenue and Volume Forecast, by Needle Length
11.1.5.3. Market Revenue and Volume Forecast, by Therapy
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product
11.2.2. Market Revenue and Volume Forecast, by Needle Length
11.2.3. Market Revenue and Volume Forecast, by Therapy
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product
11.2.4.2. Market Revenue and Volume Forecast, by Needle Length
11.2.4.3. Market Revenue and Volume Forecast, by Therapy
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product
11.2.5.2. Market Revenue and Volume Forecast, by Needle Length
11.2.5.3. Market Revenue and Volume Forecast, by Therapy
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product
11.2.6.2. Market Revenue and Volume Forecast, by Needle Length
11.2.6.3. Market Revenue and Volume Forecast, by Therapy
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product
11.2.7.2. Market Revenue and Volume Forecast, by Needle Length
11.2.7.3. Market Revenue and Volume Forecast, by Therapy
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product
11.3.2. Market Revenue and Volume Forecast, by Needle Length
11.3.3. Market Revenue and Volume Forecast, by Therapy
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product
11.3.4.2. Market Revenue and Volume Forecast, by Needle Length
11.3.4.3. Market Revenue and Volume Forecast, by Therapy
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product
11.3.5.2. Market Revenue and Volume Forecast, by Needle Length
11.3.5.3. Market Revenue and Volume Forecast, by Therapy
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product
11.3.6.2. Market Revenue and Volume Forecast, by Needle Length
11.3.6.3. Market Revenue and Volume Forecast, by Therapy
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product
11.3.7.2. Market Revenue and Volume Forecast, by Needle Length
11.3.7.3. Market Revenue and Volume Forecast, by Therapy
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product
11.4.2. Market Revenue and Volume Forecast, by Needle Length
11.4.3. Market Revenue and Volume Forecast, by Therapy
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product
11.4.4.2. Market Revenue and Volume Forecast, by Needle Length
11.4.4.3. Market Revenue and Volume Forecast, by Therapy
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product
11.4.5.2. Market Revenue and Volume Forecast, by Needle Length
11.4.5.3. Market Revenue and Volume Forecast, by Therapy
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product
11.4.6.2. Market Revenue and Volume Forecast, by Needle Length
11.4.6.3. Market Revenue and Volume Forecast, by Therapy
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product
11.4.7.2. Market Revenue and Volume Forecast, by Needle Length
11.4.7.3. Market Revenue and Volume Forecast, by Therapy
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product
11.5.2. Market Revenue and Volume Forecast, by Needle Length
11.5.3. Market Revenue and Volume Forecast, by Therapy
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product
11.5.4.2. Market Revenue and Volume Forecast, by Needle Length
11.5.4.3. Market Revenue and Volume Forecast, by Therapy
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product
11.5.5.2. Market Revenue and Volume Forecast, by Needle Length
11.5.5.3. Market Revenue and Volume Forecast, by Therapy
12.1. Becton, Dickinson and Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Novo Nordisk A/S
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ypsomed AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Owen Mumford Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. HTL-STREFA S.A.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Terumo Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Allison Medical, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Artsana S.p.A.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Trividia Health, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Perrigo Company plc
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample